Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
| Actual shortage: | 232 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2017-03-22 | 2017-05-02 | 3909 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Resolved | 2017-03-20 | 2017-05-02 | 3622 |
| APO-QUINAPRIL | 10MG | TABLET | Resolved | 2017-03-11 | 2017-05-02 | 453 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2017-04-19 | 2017-05-01 | 7234 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2017-03-17 | 2017-05-01 | 3186 |
| APO-ABACAVIR | 300MG | TABLET | Resolved | 2017-03-10 | 2017-04-28 | 8 |
| APO-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2017-03-10 | 2017-04-27 | 399 |
| APO-EZETIMIBE | 10MG | TABLET | Resolved | 2017-04-04 | 2017-04-25 | 5366 |
| APO-EZETIMIBE | 10MG | TABLET | Resolved | 2017-03-11 | 2017-04-25 | 655 |
| APO-AMOXI CLAV | 875MG 125MG | TABLET | Resolved | 2017-03-11 | 2017-04-25 | 636 |
| APO-CEFADROXIL | 500MG | CAPSULE | Resolved | 2017-04-17 | 2017-04-25 | 7102 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-03-20 | 2017-04-24 | 3533 |
| APO-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 351 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 345 |
| APO-ACYCLOVIR | 200MG | TABLET | Resolved | 2017-03-11 | 2017-04-21 | 630 |
| APO-ACYCLOVIR | 800MG | TABLET | Resolved | 2017-03-10 | 2017-04-21 | 21 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Resolved | 2017-03-12 | 2017-04-21 | 686 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2017-03-13 | 2017-04-20 | 745 |
| APO-TRAMADOL | 50MG | TABLET | Resolved | 2017-03-12 | 2017-04-17 | 692 |
| APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2017-03-12 | 2017-04-17 | 719 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
| APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
| APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-02-21 | 70802 |
| APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Discontinued | 2018-09-07 | 2019-02-13 | 60426 |
| APO-TADALAFIL | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-02-13 | 61045 |
| APO-DONEPEZIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60453 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60769 |
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
| APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
| APO-CITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60393 |
| APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |